Immunohistochemical Profiles of Dermatofibroma and Dermatofibrosarcoma Protuberans

This review summarizes the immunohistochemical profiles of dermatofibroma (DF) and dermatofibrosarcoma protuberans (DFSP) as reported by primary literature in the past 10 years. 63 studies were included in the review, with staining information for a total of 99 unique IHC markers reported. The most commonly reported stains were CD34, SMA, S100, and FXIIIa. Most studies applied IHC either to explore descriptive features of DF or DFSP or to determine their utility in diagnostic identification of the lesions. Importantly, summary data of percent positivity for key markers such as CD34 and FXIIIa highlights gaps in the existing diagnostic paradigm using these markers alone. A number of studies applied novel biomarkers that may hold promise for distinguishing DF and DFSP, namely WT1, Cx43, LSP-1, and PHH3, which demonstrated considerable expression differences between the 2 lesions. This review highlights the need for validation of existing and emerging IHC markers for the diagnosis of DF and DFSP.

Authors

Institutions

Publication Details

Journal
Applied immunohistochemistry & molecular morphology
Published
2025-10-28
DOI
https://doi.org/10.1097/pai.0000000000001284
Citations
1
Primary Topic
Sarcoma Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
1.52
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Immunohistochemical Profiles of Dermatofibroma and Dermatofibrosarcoma Protuberans

Loma Dave, William Fitzmaurice, Ali Razavi, Céline Hardy et al.
1 citations
Applied immunohistochemistry & molecular morphology
Sarcoma Diagnosis and Treatment
1.52
article

Immunohistochemical Profiles of Dermatofibroma and Dermatofibrosarcoma Protuberans

Loma Dave, William Fitzmaurice, Ali Razavi, Céline Hardy, Kaitlin Vanderbeck, Ramsay Farah, Natalie Nunez, Amy R. Slutzky
article en
1 citations

Abstract

This review summarizes the immunohistochemical profiles of dermatofibroma (DF) and dermatofibrosarcoma protuberans (DFSP) as reported by primary literature in the past 10 years. 63 studies were included in the review, with staining information for a total of 99 unique IHC markers reported. The most commonly reported stains were CD34, SMA, S100, and FXIIIa. Most studies applied IHC either to explore descriptive features of DF or DFSP or to determine their utility in diagnostic identification of the lesions. Importantly, summary data of percent positivity for key markers such as CD34 and FXIIIa highlights gaps in the existing diagnostic paradigm using these markers alone. A number of studies applied novel biomarkers that may hold promise for distinguishing DF and DFSP, namely WT1, Cx43, LSP-1, and PHH3, which demonstrated considerable expression differences between the 2 lesions. This review highlights the need for validation of existing and emerging IHC markers for the diagnosis of DF and DFSP.

Applied immunohistochemistry & molecular morphologyVol. 34(1)
University of Toronto (CA), SUNY Upstate Medical University (US)
Openalex Percentile: Top 13%
Sarcoma Diagnosis and Treatment
1.52
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Immunohistochemical Profiles of Dermatofibroma and Dermatofibrosarcoma Protuberans — Loma Dave, William Fitzmaurice, et al. · Applied immunohistochemistry & molecular morphology (2025) | TGRS Research Map | TGRS